These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18354209)

  • 1. Complement factor H-binding protein, a putative virulence determinant of Borrelia hermsii, is an antigenic target for protective B1b lymphocytes.
    Colombo MJ; Alugupalli KR
    J Immunol; 2008 Apr; 180(7):4858-64. PubMed ID: 18354209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B1b lymphocytes confer T cell-independent long-lasting immunity.
    Alugupalli KR; Leong JM; Woodland RT; Muramatsu M; Honjo T; Gerstein RM
    Immunity; 2004 Sep; 21(3):379-90. PubMed ID: 15357949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B1b lymphocyte-derived antibodies control Borrelia hermsii independent of Fcα/μ receptor and in the absence of host cell contact.
    Colombo MJ; Abraham D; Shibuya A; Alugupalli KR
    Immunol Res; 2011 Dec; 51(2-3):249-56. PubMed ID: 22139824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Borrelia hermsii factor H binding protein FhbA is not required for infectivity in mice or for resistance to human complement in vitro.
    Fine LM; Miller DP; Mallory KL; Tegels BK; Earnhart CG; Marconi RT
    Infect Immun; 2014 Aug; 82(8):3324-32. PubMed ID: 24866803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes.
    Alugupalli KR; Gerstein RM; Chen J; Szomolanyi-Tsuda E; Woodland RT; Leong JM
    J Immunol; 2003 Apr; 170(7):3819-27. PubMed ID: 12646649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and molecular analyses of the Borrelia hermsii factor H and factor H-like protein 1 binding protein, FhbA: demonstration of its utility as a diagnostic marker and epidemiological tool for tick-borne relapsing fever.
    Hovis KM; Schriefer ME; Bahlani S; Marconi RT
    Infect Immun; 2006 Aug; 74(8):4519-29. PubMed ID: 16861638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses.
    Alugupalli KR; Akira S; Lien E; Leong JM
    J Immunol; 2007 Mar; 178(6):3740-9. PubMed ID: 17339472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever.
    Vuyyuru R; Liu H; Manser T; Alugupalli KR
    Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20707-12. PubMed ID: 22143787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell-independent immune responses do not require CXC ligand 13-mediated B1 cell migration.
    Colombo MJ; Sun G; Alugupalli KR
    Infect Immun; 2010 Sep; 78(9):3950-6. PubMed ID: 20584971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
    Belperron AA; Dailey CM; Bockenstedt LK
    J Immunol; 2005 May; 174(9):5681-6. PubMed ID: 15843569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii.
    Hovis KM; McDowell JV; Griffin L; Marconi RT
    J Bacteriol; 2004 May; 186(9):2612-8. PubMed ID: 15090501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI.
    Dickinson GS; Sun G; Bram RJ; Alugupalli KR
    Infect Immun; 2014 Jan; 82(1):453-9. PubMed ID: 24218480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an antiparallel coiled-coil/loop domain required for ligand binding by the Borrelia hermsii FhbA protein: additional evidence for the role of FhbA in the host-pathogen interaction.
    Hovis KM; Freedman JC; Zhang H; Forbes JL; Marconi RT
    Infect Immun; 2008 May; 76(5):2113-22. PubMed ID: 18299341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes.
    Rossmann E; Kraiczy P; Herzberger P; Skerka C; Kirschfink M; Simon MM; Zipfel PF; Wallich R
    J Immunol; 2007 Jun; 178(11):7292-301. PubMed ID: 17513779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analyses of the interaction of Borrelia hermsii FhbA with the complement regulatory proteins factor H and factor H-like protein 1.
    Hovis KM; Jones JP; Sadlon T; Raval G; Gordon DL; Marconi RT
    Infect Immun; 2006 Apr; 74(4):2007-14. PubMed ID: 16552029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection.
    Dickinson GS; Piccone H; Sun G; Lien E; Gatto L; Alugupalli KR
    Infect Immun; 2010 Nov; 78(11):4579-88. PubMed ID: 20696824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Borrelia immune evasion by FhbA-related proteins.
    Kogan K; Haapasalo K; Kotila T; Moore R; Lappalainen P; Goldman A; Meri T
    PLoS Pathog; 2022 Mar; 18(3):e1010338. PubMed ID: 35303742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with the variable tick protein of the relapsing fever spirochete Borrelia hermsii protects mice from infection by tick-bite.
    Krajacich BJ; Lopez JE; Raffel SJ; Schwan TG
    Parasit Vectors; 2015 Oct; 8():546. PubMed ID: 26490040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual role of MyD88 in rapid clearance of relapsing fever Borrelia spp.
    Bolz DD; Sundsbak RS; Ma Y; Akira S; Weis JH; Schwan TG; Weis JJ
    Infect Immun; 2006 Dec; 74(12):6750-60. PubMed ID: 17030581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies.
    Barbour AG; Bundoc V
    Infect Immun; 2001 Feb; 69(2):1009-15. PubMed ID: 11159997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.